Evidence map›Paper›PMID 26800189›Full record

ArticlePloS one2016

Metabolites in Blood for Prediction of Bacteremic Sepsis in the Emergency Room.

Anna M Kauppi, Alicia Edin, Ingrid Ziegler, Paula Mölling, Anders Sjöstedt, Åsa Gylfe, Kristoffer Strålin, Anders Johansson

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03314831 (The Role of Myristic Acid in Serum for Early Diagnosis of Sepsis and Comparison With Selected Biomarkers of Sepsis - Procalcitonin, Presepsin. Correlation With Blood Culture and Detection of Infection by Molecular Biological Methods), which is not on this map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03314831 completednot on this mapstarted 2017, after this paper: background citation

The Role of Myristic Acid in Serum for Early Diagnosis of Sepsis and Comparison With Selected Biomarkers of Sepsis - Procalcitonin, Presepsin. Correlation With Blood Culture and Detection of Infection by Molecular Biological Methods

TypeobservationalSponsorCharles University, Czech RepublicRan2017 to 2022Enrolled282ConditionsSepsis Syndrome, Systemic Inflammatory Response Syndrome
3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Early Prediction of Septic Shock in Emergency Department Using Serum Metabolites.Journal of the American Society for Mass Spectrometry · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Host Response Biomarkers for Sepsis in the Emergency Room.Critical care (London, England) · 2023
    Review
  13. Article
  14. Sepsis as a Challenge for Personalized Medicine.Journal of personalized medicine · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Anna M KauppiDepartment of Clinical Microbiology, Clinical Bacteriology, the Laboratory for Molecular Infection Medicine Sweden and Umeå Centre for Microbial Research, Umeå University, Umeå, Sweden.
Alicia EdinDepartment of Clinical Microbiology, Clinical Bacteriology, the Laboratory for Molecular Infection Medicine Sweden and Umeå Centre for Microbial Research, Umeå University, Umeå, Sweden.
Ingrid ZieglerDepartment of Infectious Diseases, Örebro University Hospital, Örebro, Sweden.
Paula MöllingDepartment of Laboratory Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Anders SjöstedtDepartment of Clinical Microbiology, Clinical Bacteriology, the Laboratory for Molecular Infection Medicine Sweden and Umeå Centre for Microbial Research, Umeå University, Umeå, Sweden.
Åsa GylfeDepartment of Clinical Microbiology, Clinical Bacteriology, the Laboratory for Molecular Infection Medicine Sweden and Umeå Centre for Microbial Research, Umeå University, Umeå, Sweden.
Kristoffer StrålinDepartment of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
Anders JohanssonDepartment of Clinical Microbiology, Clinical Bacteriology, the Laboratory for Molecular Infection Medicine Sweden and Umeå Centre for Microbial Research, Umeå University, Umeå, Sweden.
Umeå University · SEKarolinska University Hospital · SEÖrebro University · SEÖrebro University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A metabolomics approach for prediction of bacteremic sepsis in patients in the emergency room (ER) was investigated. In a prospective study, whole blood samples from 65 patients with bacteremic sepsis and 49 ER controls were compared. The blood samples were analyzed using gas chromatography coupled to time-of-flight mass spectrometry. Multivariate and logistic regression modeling using metabolites identified by chromatography or using conventional laboratory parameters and clinical scores of infection were employed. A predictive model of bacteremic sepsis with 107 metabolites was developed and validated. The number of metabolites was reduced stepwise until identifying a set of 6 predictive metabolites. A 6-metabolite predictive logistic regression model showed a sensitivity of 0.91(95% CI 0.69-0.99) and a specificity 0.84 (95% CI 0.58-0.94) with an AUC of 0.93 (95% CI 0.89-1.01). Myristic acid was the single most predictive metabolite, with a sensitivity of 1.00 (95% CI 0.85-1.00) and specificity of 0.95 (95% CI 0.74-0.99), and performed better than various combinations of conventional laboratory and clinical parameters. We found that a metabolomics approach for analysis of acute blood samples was useful for identification of patients with bacteremic sepsis. Metabolomics should be further evaluated as a new tool for infection diagnostics.

Indexed as

Emergency Service, HospitalAgedBacteremiaBiomarkersCase-Control StudiesDisaccharidesFemaleGlucuronatesHumansMaleMetabolomicsMyristic AcidSensitivity and SpecificityBiomarkersDisaccharidesGlucuronatesMyristic AcidO-(glucuronic acid 2-sulfate)-(1--4)-O-(2,5)-anhydromannitol 6-sulfate

Identifiers

PMID26800189
PMCPMC4723089
OpenAlexW2411102340

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.